Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCAR-T 2019 e-learning
View iwCAR-T 2019 webcasts now!
The 1st International Workshop on CAR-T (iwCAR-T) took place on October 11–13, 2019, in Miami, FL. The inaugural meeting brought together leading experts in the field to discuss the considerations of this emerging immunotherapy for hematological malignancies.
These e-learning webcasts will help consolidate your knowledge on the key themes surrounding CAR T-cell therapy, including toxicity issues, the evolution of cellular therapies, overcoming resistance mechanisms, as well as its use in CLL, acute leukemias, multiple myeloma, and lymphoma.
You can view each presentation simply by clicking on its title.
Please note that presentations from Session V are unavailable due to unpublished data.
Session I: CAR-T in ALL
Session III: CAR-T in Lymphoma
▶ Axicabtagene ciloleucel for large B-cell lymphoma
Frederick Locke
▶ Update on TRANSCEND NHL-001: lisocabtagene maraleucel
Caron Jacobson
▶ BMT vs CAR-T in second-line DLBCL
Ian Flinn
▶ CAR T-cell approaches to T-cell lymphoma
Matthew Frigault
▶ CAR T-cell therapy in follicular lymphoma
Loretta Nastoupil
Session VII: CAR-T in Multiple Myeloma
▶ Universal SLAMF7-specific CAR T-cells (UCARTCS1) for multiple myeloma
Krina Patel
▶ New targets and technologies for CAR-T: moving beyond ‘state-of-the-art’
Hardikkumar Jetani
▶ LCAR-B38M/JNJ-4528: global CAR-T development perspectives
Tonia Nesheiwat & Jordan Schecter
Session VIII: Evolution of Cellular Therapies
Explore More CAR T-Cell Therapy Content on VJHemOnc
